[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:gata2-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"GATA2 Gene",4,[7,15,21,27],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06152809","CIML NK Cells With Venetoclax for AML",[11],"Phase 1","RECRUITING","2026-08-26T02:15:47.754948Z","2026-05-05T02:43:28.162326Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT02958462","Pre-myeloid Cancer and Bone Marrow Failure Clinic Study",[],"2026-08-26T02:16:16.995720Z","2026-05-05T02:43:27.746243Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT00001467","Genetic Analysis of Immune Disorders",[],"2026-08-26T02:17:05.997056Z","2026-07-19T19:36:05.116913Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":31,"content_modified":32},"NCT01212055","Apheresis of Patients With Immunodeficiency",[],"2026-08-26T02:16:56.877406Z","2026-05-13T02:55:06.069841Z"]